UK pharmaceuticals rose in early trading after speculation mounted President Barrack Obama's healthcare reforms could be thwarted by the Republicans.
News that the party had taken an extra seat in Massachusetts, giving it enough seats in the Senate to block Obama's proposals, buoyed the sector worldwide. Nevertheless, the FTSE index fell by 0.2% to 5504.67 points in early trading. It still sits about 35% higher than its 52-week low of 3512.09. In the UK, Shire Plc rose by 1.8% to £12.51, while GlaxoSmithKline, 40% of whose sales are in the US, rose 1.7% to £13.06. Rival AstraZeneca also rose, by 0.83% to £25.50. Barclays, which fell yesterday after broker Credit Suisse said it could be forced to raise fresh capital to satisfy ca...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes